Documents Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 /...

Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic colorectal…

Documents XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III...

XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III trial of first-line treatment for patients with metastatic colorectal cancer…

Documents TAP Vol 1 Issue 6

A Harborside Press Publication Editor-in-Chief, James O. Armitage, MD ASCOPost.com VOLUME 1, ISSUE 6 NOVEMBER 2010 continued on page 3 continued on page 6 MORE IN THIS ISSUE…